JWS Consulting is a division of Johnson Winter & Slattery providing commercial consulting services.
We are engaged by major Australian and international corporations as legal counsel on their business activities, disputes and most challenging matters.
Established in 1993 by Tony Johnson, Nigel Winter and Peter Slattery as a boutique corporate firm, JWS grew rapidly to become a leading independent Australian firm.
The quality of our legal advice and service to clients is recognised through independent industry recognition and direct client feedback.
Learn more about breaking news at Johnson Winter & Slattery, including major transaction announcements, practitioner appointments and team expansions.
JWS supports a number of community initiatives and not for profit organisations across Australia through pro bono legal work, charitable donations and sponsorships.
In 2018, we celebrate 25 years of long-lasting relationships with our valued clients.
Our consumer goods practice is one of the leading FMCG practices in Australia, and we assist our clients in all aspects of their business from product development through to sales and consumer issues.
We represent many well-known FMCG companies with numerous household brands including Ferrero (ROCHER®, TIC TAC®, NUTELLA®), Pepsi (PEPSI®, SMITH’S®, TWISTIES®, SAKATA®) and Beiersdorf (NIVEA®, ELASTOPLAST®, LEUKO®).
We advise our clients on R&D agreements, compliance with relevant standards, brand development, labelling and packaging, manufacturing agreements, distribution agreements, advertising agreements and advice on promotional activities including trade promotions.
We also advise clients on all aspects of laws and mandatory standards relating to consumer products including:
On 19 June 2018, the Federal Court of Australia ordered Apple Inc (Apple US) to pay penalties of $9 million for making false and misleading representations to customers about their rights under the...
Last month, the Full Federal Court ordered Japanese company Yazaki Corporation (Yazaki) to pay a penalty of $46 million for engaging in cartel conduct in contravention of the Competition and...
In May 2018, the Full Federal Court held that Pfizer did not misuse its market power under section 46 of the Competition and Consumer Act 2010 (Act) by engaging in a number of activities that...